TENX AS OF 08/31/2024

Company

TENAX THERAPEUTICS, INC.

Filed

September 10, 2024

Accession Number

0001897612-24-001393

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →